Cancer stem cells: the final frontier for glioma virotherapy.
about
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiformeThe art of gene therapy for glioma: a review of the challenging road to the bedsideOncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.An integrated transcriptomic and computational analysis for biomarker identification in human glioma.Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtype.Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.
P2860
Q34364774-968EAD24-E470-4325-9046-FA23CF35C47EQ34504805-2A2C6352-16D5-4490-A15B-86944BDE94AAQ35973436-A7788A71-B3F2-4570-A3C5-EB9ED2F078ECQ36251215-19ED38FF-BC19-472D-9EC5-B839B17FB56DQ36527593-863DD73E-4238-4788-978F-10A2476B0012Q36634430-EC25AFF4-85C4-4766-ACBA-19CA013F4E9AQ36861550-73E44A2D-5AC0-4F80-B889-7CEB11102BC9Q37154265-176C2FA3-DC8F-4F14-BB3B-D8439A6B66FFQ38025696-10A5E509-30C8-4828-B5BE-8820B23F0332Q38383345-EDD9334B-8DF6-4CE9-BB81-041D52816CE1Q38453709-983AA6B3-723D-45DD-9795-0138DC1C116AQ39160342-661787BF-17A6-4BB3-834C-FFE28FCEEF3EQ40311561-ECCB7DB6-F317-4A8A-941E-161556557A2BQ47214177-84D19B46-8CE6-42B2-950B-DD9056BAFAFBQ50128059-24BC2C90-D42E-407F-851E-3E81189F5869
P2860
Cancer stem cells: the final frontier for glioma virotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cancer stem cells: the final frontier for glioma virotherapy.
@ast
Cancer stem cells: the final frontier for glioma virotherapy.
@en
Cancer stem cells: the final frontier for glioma virotherapy.
@nl
type
label
Cancer stem cells: the final frontier for glioma virotherapy.
@ast
Cancer stem cells: the final frontier for glioma virotherapy.
@en
Cancer stem cells: the final frontier for glioma virotherapy.
@nl
prefLabel
Cancer stem cells: the final frontier for glioma virotherapy.
@ast
Cancer stem cells: the final frontier for glioma virotherapy.
@en
Cancer stem cells: the final frontier for glioma virotherapy.
@nl
P2093
P2860
P1476
Cancer stem cells: the final frontier for glioma virotherapy
@en
P2093
Adam M Sonabend
Maciej S Lesniak
Matthew A Tyler
P2860
P2888
P304
P356
10.1007/S12015-010-9132-7
P50
P577
2011-03-01T00:00:00Z
P5875
P6179
1041394979